Compounds > flucytosine

flucytosine and mannitol

flucytosine has been researched along with mannitol in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Herzog, H; Kobza, K; Kopp, C; Mihatsch, M; Perruchoud, A1
Costabile, G; d'Angelo, I; d'Emmanuele di Villa Bianca, R; Del Porto, P; Imperi, F; Leoni, L; Miro, A; Mitidieri, E; Pompili, B; Quaglia, F; Sorrentino, R; Ungaro, F; Visca, P1

Reviews

1 review(s) available for flucytosine and mannitol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

4 other study(ies) available for flucytosine and mannitol

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
[Clinical aspects and therapy of candidiasis in pneumological patients].
    Schweizerische medizinische Wochenschrift, 1977, Feb-12, Volume: 107, Issue:6

    Topics: Acidosis; Adult; Aged; Amphotericin B; Candidiasis; Drug Synergism; Drug Therapy, Combination; Female; Flucytosine; Humans; Lung Diseases, Fungal; Male; Mannitol; Middle Aged; Respiratory Insufficiency

1977
Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections.
    Journal of controlled release : official journal of the Controlled Release Society, 2016, 09-28, Volume: 238

    Topics: Administration, Inhalation; Aerosols; Animals; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candidiasis; Drug Repositioning; Dry Powder Inhalers; Flucytosine; Humans; Hyaluronic Acid; Lung; Lung Diseases, Fungal; Male; Mannitol; Particle Size; Powders; Pseudomonas aeruginosa; Pseudomonas Infections; Rats, Wistar

2016